1-5 of 5
Min Wu, PhD
Close
Sort by
Journal Articles

DOCK2 Expression Affects Leukemogenesis and Disease Progression in a Murine Model of FLT3/ITD Acute Myeloid Leukemia

Min Wu, PhD, Li Li, MD PhD, Donald Small, MD PhD, Amy S. Duffield, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2534.
https://doi.org/10.1182/blood-2019-129157
Published: 2019
Journal Articles

DOCK2 Knockdown Mitigates Disease Progression in Murine Models Harboring a FLT3/ITD Mutation

Min Wu, PhD, Li Li, MD PhD, Bao Nguyen, MS, Donald Small, MD PhD, Amy S. Duffield, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1216.
https://doi.org/10.1182/blood.V130.Suppl_1.1216.1216
Published: 2017
Journal Articles

FLT3/ITD Cooperates with Rac1/DOCK2 to Modulate the Sensitivity of Leukemic Cells to Chemotherapeutic Agents Via Regulation of DNA Repair Pathways

Min Wu, PhD, Li Li, PhD, Max Hamaker, BA, Donald Small, MD PhD, Amy S. Duffield, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2732.
https://doi.org/10.1182/blood.V128.22.2732.2732
Published: 2016
Journal Articles

DOCK2 Regulates DNA Damage Response and Modulates the Sensitivity to Chemotherapeutic Agents in FLT3/ITD Leukemic Cells

Min Wu, PhD, Li Li, PhD, Max Hamaker, BA, Donald Small, MD PhD, Amy S. Duffield, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3668.
https://doi.org/10.1182/blood.V126.23.3668.3668
Published: 2015
Journal Articles

DOCK2 Interacts with FLT3 and Modulates the Survival of FLT3-Expressing Leukemia Cells

Min Wu, PhD, Max Hamaker, BA, Li Li, PhD, Donald Small, MD PhD, Amy S. Duffield, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3584.
https://doi.org/10.1182/blood.V124.21.3584.3584
Published: 2014